naltrexone has been researched along with Acute Disease in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (12.00) | 18.7374 |
| 1990's | 5 (20.00) | 18.2507 |
| 2000's | 13 (52.00) | 29.6817 |
| 2010's | 2 (8.00) | 24.3611 |
| 2020's | 2 (8.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cook, ME; Drewes, AM; Fjelsted, CA; Frøkjær, JB; Hansen, MB; Knoph, CS; Mortensen, MB; Nielsen, LBJ; Novovic, S; Olesen, SS | 1 |
| DiPetrillo, L; Jiang, Y; Kunovac, J; McDonnell, D; Potkin, SG; Silverman, BL; Simmons, A | 1 |
| Cheng, PY; Peng, YJ; Wang, CC; Wei, HP; Wu, ES; Yen, MH | 1 |
| Botelho, AP; de Arruda Veiga, MC; Gameiro, GH; Marcondes, FK; Tuma, CE | 1 |
| Coelho, AM; D'Albuquerque, LA; Machado, MC; Molan, NT; Penido, A; Silva, FP | 1 |
| Cancela, LM; del Rosario, CN; Pacchioni, AM | 1 |
| Holtzman, SG | 1 |
| Brewer, C; Wong, VS | 1 |
| Freye, E; Levy, J | 1 |
| Kordik, CP; Levin, ED; Overstreet, DH; Reitz, AB; Rezvani, AH; Rosenthal, DI; Vaidya, AH | 1 |
| Miranda, HF; Pinardi, G; Prieto, JC; Puig, MM | 1 |
| Arout, CA; Inturrisi, CE; Juni, A; Kest, B; Klein, G; Waxman, AR | 1 |
| Jourd'Heuil, D; Lang, ME; Meddings, JB; Swain, MG | 1 |
| Planas, E; Pol, O; Puig, MM | 1 |
| Bofetiado, DM; D'Alecy, LG; Mayfield, KP | 1 |
| Henderson, CA; Reynolds, JE | 1 |
| Brady, MJ; Bruehl, S; Carlson, CR; Colclough, G; McCubbin, JA; Norton, JA; Sherman, JJ; Wilson, JF | 1 |
| Clark, WM; Kelly, RE; Raps, EC; Tong, DC | 1 |
| Crain, SM; Shen, KF | 1 |
| Bristow, K; Clark, N; Meek, R | 1 |
| Cancela, LM; del Rosario Capriles, N | 1 |
| Sareen, D | 1 |
| McNamee, HB; Meyer, RE; Mirin, SM | 1 |
| Baskin, DS; Hosobuchi, Y; Kuroda, H; Lee, NM | 1 |
| Conti, A; Maestroni, GJ; Pierpaoli, W | 1 |
2 review(s) available for naltrexone and Acute Disease
| Article | Year |
|---|---|
Naltrexone: report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature.
Topics: Acute Disease; Adult; Delayed-Action Preparations; Drug Implants; Hepatitis B; Hepatitis C; Heroin Dependence; Humans; Liver Function Tests; Male; Naltrexone; Narcotic Antagonists | 2004 |
Neuroprotective agents in acute ischemic stroke.
Topics: Acute Disease; Adult; Aged; Animals; Antioxidants; Calcium Channel Blockers; Chlormethiazole; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Forecasting; GABA Modulators; Guanidines; Humans; Imidazoles; Middle Aged; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Pipecolic Acids; Piperidines; Quinoxalines; Rats; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Stroke; Thiazoles | 2002 |
4 trial(s) available for naltrexone and Acute Disease
| Article | Year |
|---|---|
Effects of the peripherally acting μ-opioid receptor antagonist methylnaltrexone on acute pancreatitis severity: study protocol for a multicentre double-blind randomised placebo-controlled interventional trial, the PAMORA-AP trial.
Topics: Acute Disease; Humans; Multicenter Studies as Topic; Naltrexone; Narcotic Antagonists; Pancreatitis; Quaternary Ammonium Compounds; Randomized Controlled Trials as Topic; Research Design | 2021 |
Efficacy and Safety of a Combination of Olanzapine and Samidorphan in Adult Patients With an Acute Exacerbation of Schizophrenia: Outcomes From the Randomized, Phase 3 ENLIGHTEN-1 Study.
Topics: Acute Disease; Adult; Antipsychotic Agents; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Olanzapine; Outcome Assessment, Health Care; Schizophrenia; Symptom Flare Up | 2020 |
Psychological coping with acute pain: an examination of the role of endogenous opioid mechanisms.
Topics: Acute Disease; Adaptation, Psychological; Adolescent; Adult; Attention; Double-Blind Method; Humans; Male; Naltrexone; Narcotic Antagonists; Opioid Peptides; Pain; Pain Measurement; Pain Threshold; Receptors, Opioid | 1996 |
Cervene (Nalmefene) in acute ischemic stroke : final results of a phase III efficacy study. The Cervene Stroke Study Investigators.
Topics: Acute Disease; Aged; Aged, 80 and over; Brain Ischemia; Dose-Response Relationship, Drug; Double-Blind Method; Dynorphins; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nausea; Neuroprotective Agents; Receptors, Opioid, kappa; Risk Factors; Survival Analysis; Treatment Failure | 2000 |
19 other study(ies) available for naltrexone and Acute Disease
| Article | Year |
|---|---|
Naltrexone protects against lipopolysaccharide/D-galactosamine-induced hepatitis in mice.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Antioxidants; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Neutrophils; Nitrates; Nitrites; Superoxides; Time Factors; Tumor Necrosis Factor-alpha | 2008 |
The effects of acute restraint stress on nociceptive responses evoked by the injection of formalin into the temporomandibular joint of female rats.
Topics: Acute Disease; Animals; Behavior, Animal; Estrus; Female; Formaldehyde; Naltrexone; Narcotic Antagonists; Nociceptors; Pain; Pain Measurement; Proestrus; Rats; Rats, Wistar; Receptors, Opioid; Restraint, Physical; Stress, Physiological; Temporomandibular Joint; Temporomandibular Joint Disorders | 2010 |
Do opioid receptors play a role in the pathogenesis of the inflammatory response in acute pancreatitis?
Topics: Acute Disease; Amylases; Animals; Disease Models, Animal; Interleukin-6; Male; Naltrexone; Narcotic Antagonists; Pancreatitis; Peroxidase; Random Allocation; Rats; Rats, Wistar; Receptors, Opioid; Taurocholic Acid; Tumor Necrosis Factor-alpha | 2012 |
Influence of acute or repeated restraint stress on morphine-induced locomotion: involvement of dopamine, opioid and glutamate receptors.
Topics: Acute Disease; Animals; Benzazepines; Chronic Disease; Dizocilpine Maleate; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Excitatory Amino Acid Antagonists; Male; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid; Restraint, Physical; Stress, Psychological; Sulpiride | 2002 |
Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
Topics: Acute Disease; Analgesics, Opioid; Animals; Disease Models, Animal; Fentanyl; Male; Methadone; Morphine; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Substance-Related Disorders | 2003 |
Constitutive opioid receptor activation: a prerequisite mechanism involved in acute opioid withdrawal.
Topics: Acute Disease; Animals; Biotransformation; Dogs; Evoked Potentials, Somatosensory; Naltrexone; Narcotics; Protein Kinase C; Receptors, Opioid; Somatoform Disorders; Substance Withdrawal Syndrome; Sufentanil | 2005 |
Effects of atypical anxiolytic N-phenyl-2-[1-[3-(2-pyridinylethynyl)benzoyl]-4-piperidine]acetamide (JNJ-5234801) on alcohol intake in alcohol-preferring P rats.
Topics: Acute Disease; Alcohol Drinking; Animals; Anti-Anxiety Agents; Chronic Disease; Dose-Response Relationship, Drug; Drinking; Drug Tolerance; Injections, Intraperitoneal; Male; Naltrexone; Narcotic Antagonists; Piperidines; Pyridines; Rats | 2007 |
Isobolographic analysis of multimodal analgesia in an animal model of visceral acute pain.
Topics: Acetaminophen; Acute Disease; Adrenergic alpha-Antagonists; Analgesics; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Atropine; Behavior, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Ketoprofen; Male; Mice; Morphine; Muscarinic Antagonists; Naltrexone; Narcotic Antagonists; Pain; Prazosin | 2008 |
Acute and chronic heroin dependence in mice: contribution of opioid and excitatory amino acid receptors.
Topics: Acute Disease; Animals; Behavior, Animal; Benzylidene Compounds; Chronic Disease; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Heroin Dependence; Male; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, AMPA; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Time Factors | 2008 |
Increased opioid binding to peripheral white blood cells in a rat model of acute cholestasis.
Topics: Acute Disease; Animals; Cholestasis; Disease Models, Animal; Enkephalins; Flow Cytometry; Leukocytes; Lymphocytes; Male; Monocytes; Naltrexone; Neutrophils; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu | 1995 |
Peripheral effects of naloxone in mice with acute diarrhea associated with intestinal inflammation.
Topics: Acute Disease; Animals; Benzomorphans; Croton Oil; Diarrhea; Enteritis; Gastrointestinal Motility; Male; Mice; Naloxone; Naltrexone; Quaternary Ammonium Compounds; Receptors, Opioid, delta; Receptors, Opioid, kappa | 1995 |
Alkaloid delta agonist BW373U86 increases hypoxic tolerance.
Topics: Acute Disease; Animals; Benzamides; Body Temperature; Dose-Response Relationship, Drug; Hypoxia; Male; Mice; Mice, Inbred Strains; Naltrexone; Narcotic Antagonists; Piperazines; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1996 |
Acute pulmonary edema in a young male after intravenous nalmefene.
Topics: Acute Disease; Adult; Analgesics, Opioid; Anesthesia; Humans; Infusions, Intravenous; Male; Morphine; Naltrexone; Narcotic Antagonists; Pulmonary Edema | 1997 |
Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia.
Topics: Acute Disease; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Etorphine; Hot Temperature; Hyperalgesia; Male; Mice; Morphine; Morphine Dependence; Naltrexone; Narcotic Antagonists; Pain Threshold; Receptors, Opioid | 2001 |
Acute opioid withdrawal in the emergency department: inadvertent naltrexone abuse?
Topics: Acute Disease; Adult; Colic; Emergency Medical Services; Female; Heroin; Heroin Dependence; Humans; Injections, Intravenous; Naltrexone; Narcotics; Substance Withdrawal Syndrome; Vomiting | 2001 |
Motivational effects mu- and kappa-opioid agonists following acute and chronic restraint stress: involvement of dopamine D(1) and D(2) receptors.
Topics: Acute Disease; Animals; Behavior, Animal; Benzomorphans; Chronic Disease; Conditioning, Operant; Injections, Intraventricular; Male; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Opioid, kappa; Receptors, Opioid, mu; Stress, Psychological | 2002 |
Psychopathology and mood during heroin use: acute vs chronic effects.
Topics: Acute Disease; Adult; Chronic Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Emotions; Euphoria; Heroin; Heroin Dependence; Humans; Male; Methadone; Morphine; Motor Activity; Naloxone; Naltrexone; Psychopathology | 1976 |
Treatment of stroke with opiate antagonists--effects of exogenous antagonists and dynorphin 1-13.
Topics: Acute Disease; Animals; Brain Ischemia; Cats; Dynorphins; Enkephalin, Leucine; Male; Naloxone; Naltrexone; Narcotic Antagonists; Peptide Fragments | 1985 |
Role of the pineal gland in immunity. III. Melatonin antagonizes the immunosuppressive effect of acute stress via an opiatergic mechanism.
Topics: Acute Disease; Animals; Antibody Formation; Endorphins; Female; Immune Tolerance; Melatonin; Mice; Mice, Inbred BALB C; Naltrexone; Pineal Gland; Stress, Psychological; Thymus Gland | 1988 |